Tibulizumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Zura Bio Inc
Overview
Tibulizumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tibulizumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tibulizumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.